- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CHUGAI PHARMACEUTICAL CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| Fr | Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai | 15 | Japan Times | ||
| 09.01. | Araris Biotech kooperiert mit Chugai Pharmaceutical | 4 | punkt4.info | ||
| 08.01. | Chugai and Araris enter $780m ADC research collaboration | 4 | Pharmaceutical Technology | ||
| 17.12.24 | Warum die Chugai-Aktie am Dienstag einen Sprung machte | 8 | Investing.com Deutsch | ||
| 17.12.24 | Why Chugai stock jumped on Tuesday | 3 | Investing.com | ||
| 30.07.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.07.2024 | 905 | Xetra Newsboard | The following instruments on XETRA do have their first trading 30.07.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.07.2024
Aktien
1 US1712691039 Chugai Pharmaceutical... ► Artikel lesen | |
| 24.06.24 | Chugai Pharmaceutical-Aktie heute gut behauptet: Aktienwert steigt (31,305 €) | 960 | ARIVA.de | An der Börse notiert die Chugai Pharmaceutical-Aktie gegenwärtig etwas fester. Das Wertpapier notiert aktuell bei 31,31 Euro. Der Anteilsschein von Chugai Pharmaceutical verzeichnet derzeit einen Preisanstieg... ► Artikel lesen | |
| 12.06.24 | Helsinn Healthcare S.A.: Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland | 1.094 | GlobeNewswire (Europe) | Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland
Lugano, Switzerland - June 12, 2024 - Helsinn Group ("Helsinn"), a global... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TRULIEVE CANNABIS | 3,550 | +2,54 % | Trulieve Cannabis Corp.: Trulieve Announces Appointment of Ryan Blust as Interim Chief Financial Officer | TALLAHASSEE, Fla., March 7, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing... ► Artikel lesen | |
| WEST PHARMACEUTICAL SERVICES | 194,10 | +0,88 % | West Pharmaceutical Q1 2025 Earnings Preview | ||
| KALA BIO | 2,668 | -4,37 % | KALA BIO, Inc.: KALA BIO Announces Chief Executive Officer Transition | ARLINGTON, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative... ► Artikel lesen | |
| SHIONOGI | 14,900 | -1,32 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
| CHARLOTTES WEB | 0,057 | +7,62 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results | 2024 Delivered Quarterly Growth and Large Scale Cost Optimization
LOUISVILLE, Colo., March 19, 2025 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's... ► Artikel lesen | |
| BEXIMCO | 0,442 | +7,80 % | Dividendenbekanntmachungen (22.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASSURED GUARANTY LTD BMG0585R1060 0,31 USD 0,2959 EUR BADGER METER INC US0565251081 0,34 USD 0,3245 EUR BANK CENTRAL ASIA TBK ADR US69368G1058 0... ► Artikel lesen | |
| LUYE PHARMA | 0,220 | +2,80 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT ROTIGOTINE LUYE TRANSDERMAL PATCH LAUNCHED IN THE UNITED KINGDOM | ||
| GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc.: Guardion Health Sciences Announces Filing of Certificate of Dissolution | HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ("Guardion" or the "Company") today announced that it has filed a certificate of dissolution with the... ► Artikel lesen | |
| PERCHERON THERAPEUTICS | 0,006 | 0,00 % | PERCHERON THERAPEUTICS LIMITED: Change of Interest of Substantial Holder from PVL | ||
| MIRUM PHARMACEUTICALS | 35,800 | +2,29 % | Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates | FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today provided its preliminary and unaudited estimates for full-year 2024 net product sales, year-end cash balance... ► Artikel lesen | |
| AYURCANN | 0,009 | +5,88 % | Ayurcann Holdings Corp.: Ayurcann Reports Another Record Sales Growth In Q2 2025 Of $13,363,509 | Toronto, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company") is excited to announce record-breaking financial results for the... ► Artikel lesen | |
| EVEREST MEDICINES | 5,550 | +3,74 % | Everest Medicines Limited: Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange | SHANGHAI, CHINA, Apr 22, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing... ► Artikel lesen | |
| AVANT BRANDS | 0,610 | +4,27 % | Avant Brands Inc.: Avant Brands Announces its Annual General and Special Meeting of Shareholders | KELOWNA, BC / ACCESS Newswire / April 22, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products... ► Artikel lesen | |
| KALBE FARMA | 0,058 | +2,65 % | KLBF potentially distribute 45% to 55% dividend for 2024: KLBF has the potential to distribute 45% to ... | ||
| KOBAYASHI PHARMACEUTICAL | 33,200 | +0,61 % | Dividendenbekanntmachungen (27.12.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 3 JPY 0,0182 EUR AGC INC JP3112000009 105 JPY 0,6373 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0... ► Artikel lesen |
CHUGAI PHARMACEUTICAL CO LTD ADR gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von +0,400 (+1,63 %) liegt der Kurs bei 25,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHUGAI PHARMACEUTICAL CO LTD ADR finden Sie auf Wallstreet Online.
